Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating in the in-vitro diagnostics and healthcare solutions segment, saw strong subscription on its first day. Proceeds will be… For the full story, visit the source.
BusinessUttar Pradesh
Vikas Khemani-backed Q-Line Biotech IPO subscribed over 2 times on Day 1 as GMP soars to 42%
Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating in the in-vitro diagnostics and healthcare solutions segment, saw strong subscription on its first day. Proceeds will be…
By Akash Podishetti· The Times of India· 5 months ago· 2 min read
This summary is sourced from The Times of India. Read the full article at:The Times of India